Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Stringer

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Obstetrics and Gynecology|November 1, 1987
Treatment of metastatic stromal tumors of the ovary with cisplatin, doxorubicin, and cyclophosphamideD M Gershenson, L J Copeland, J J Kavanagh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1987
Cisplatin therapy for disseminated mixed mesodermal sarcoma of the uterusD M Gershenson, J J Kavanagh, L J Copeland, et al.
Obstetrics and Gynecology|January 1, 1988
Diagnosis of recurrent cervical carcinoma after radical hysterectomyD M Larson, L J Copeland, J M Malone, et al.
Cancer|April 15, 1988
Stage II endometrial carcinoma. Results and complications of a combined radiotherapeutic-surgical approachD M Larson, L J Copeland, H S Gallager, et al.
Obstetrics and Gynecology|March 1, 1987
Stage IB cervical carcinoma treated with radical hysterectomy and pelvic lymphadenectomy: role of adjuvant radiotherapyD M Larson, C A Stringer, L J Copeland, et al.
Obstetrics and Gynecology|April 1, 1987
Ureteral assessment after radical hysterectomyD M Larson, J M Malone, L J Copeland, et al.
Gynecologic Oncology|April 2, 2002
Phase I study of alternating doublets of topotecan/carboplatin and paclitaxel/carboplatin in patients with newly diagnosed, advanced ovarian cancerAlan N Gordon, Kenneth C Hancock, Carolyn M Matthews, et al.
Gynecologic Oncology|October 1, 1994
Postoperative adjuvant cisplatin, doxorubicin, and cyclophosphamide (PAC) chemotherapy in women with high-risk endometrial carcinomaT W Burke, D M Gershenson, M Morris, et al.
Gynecologic Oncology|March 1, 1991
Prospective treatment of advanced or recurrent endometrial carcinoma with cisplatin, doxorubicin, and cyclophosphamideT W Burke, C A Stringer, M Morris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1990
Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide, and cisplatinD M Gershenson, M Morris, A Cangir, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Obstetrics and Gynecology|November 1, 1987
Treatment of metastatic stromal tumors of the ovary with cisplatin, doxorubicin, and cyclophosphamideD M Gershenson, L J Copeland, J J Kavanagh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1987
Cisplatin therapy for disseminated mixed mesodermal sarcoma of the uterusD M Gershenson, J J Kavanagh, L J Copeland, et al.
Obstetrics and Gynecology|January 1, 1988
Diagnosis of recurrent cervical carcinoma after radical hysterectomyD M Larson, L J Copeland, J M Malone, et al.
Cancer|April 15, 1988
Stage II endometrial carcinoma. Results and complications of a combined radiotherapeutic-surgical approachD M Larson, L J Copeland, H S Gallager, et al.
Obstetrics and Gynecology|March 1, 1987
Stage IB cervical carcinoma treated with radical hysterectomy and pelvic lymphadenectomy: role of adjuvant radiotherapyD M Larson, C A Stringer, L J Copeland, et al.
Obstetrics and Gynecology|April 1, 1987
Ureteral assessment after radical hysterectomyD M Larson, J M Malone, L J Copeland, et al.
Gynecologic Oncology|April 2, 2002
Phase I study of alternating doublets of topotecan/carboplatin and paclitaxel/carboplatin in patients with newly diagnosed, advanced ovarian cancerAlan N Gordon, Kenneth C Hancock, Carolyn M Matthews, et al.
Gynecologic Oncology|October 1, 1994
Postoperative adjuvant cisplatin, doxorubicin, and cyclophosphamide (PAC) chemotherapy in women with high-risk endometrial carcinomaT W Burke, D M Gershenson, M Morris, et al.
Gynecologic Oncology|March 1, 1991
Prospective treatment of advanced or recurrent endometrial carcinoma with cisplatin, doxorubicin, and cyclophosphamideT W Burke, C A Stringer, M Morris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1990
Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide, and cisplatinD M Gershenson, M Morris, A Cangir, et al.
Pageof 5